{"result": "(\"entity\"<|>IARC<|>ORGANIZATION<|>The International Agency for Research on Cancer (IARC) is an intergovernmental agency that conducts research on cancer and its causes, including the relationship between obesity and cancer.)\n##\n(\"entity\"<|>BUPROPION-NALTREXONE<|>EVENT<|>Bupropion-naltrexone is a combination pharmacotherapy used for weight loss, particularly effective in patients with appetite control issues.)\n##\n(\"entity\"<|>BILL SK<|>PERSON<|>Bill SK is a researcher who has contributed to the pharmacological understanding of naltrexone/bupropion for obesity treatment.)\n##\n(\"entity\"<|>GASTRECTOMÍA VERTICAL<|>EVENT<|>Vertical gastrectomy is a surgical procedure for weight loss that involves removing a portion of the stomach.)\n##\n(\"entity\"<|>BYPASS GÁSTRICO<|>EVENT<|>Gastric bypass is a type of weight loss surgery that alters the digestive system to help patients lose weight.)\n##\n(\"entity\"<|>MINI-BYPASS GÁSTRICO<|>EVENT<|>Mini-gastric bypass is a less invasive surgical procedure for weight loss that creates a smaller stomach pouch.)\n##\n(\"relationship\"<|>BUPROPION-NALTREXONE<|>IARC<|>The IARC studies the effects of pharmacotherapies like bupropion-naltrexone on obesity and cancer risk<|>7)\n##\n(\"relationship\"<|>BILL SK<|>IARC<|>Bill SK has published research reviewed by the IARC regarding obesity treatments and their implications<|>6)\n##\n(\"relationship\"<|>BUPROPION-NALTREXONE<|>GASTRECTOMÍA VERTICAL<|>Bupropion-naltrexone is indicated for patients who may also be candidates for surgical interventions like vertical gastrectomy<|>5)\n##\n(\"relationship\"<|>BUPROPION-NALTREXONE<|>BYPASS GÁSTRICO<|>Bupropion-naltrexone is often discussed in the context of surgical weight loss options such as gastric bypass<|>5)\n##\n(\"relationship\"<|>BUPROPION-NALTREXONE<|>MINI-BYPASS GÁSTRICO<|>Bupropion-naltrexone may be considered for patients who have undergone or are considering mini-gastric bypass<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ness and cancer—viewpoint of the IARC\n     Working Group. N Engl J Med. 2016;375:794-8.\n\n\n\n8  Señale la respuesta falsa en relación con el tratamiento médico de la obesidad:                                                        Figura 6. Mecanismo de acción de bupropión-naltrexona.\n                                                                                                                                          α-MSH: hormona estimulante de melanocitos; POMC: proopiomelanocortina; R-MC4: receptor melanocortina-4.\n   A. La combinación del agonista noradrenérgico fentermina con el antiepiléptico topiramato                                              Modificado de: Billes SK. Pharmacol Res. 2014;84:1-11.\n       (15 mg/92 mg) ha demostrado su eficacia en la pérdida de peso y en el mantenimiento                                                Referencias:\n       del peso perdido a 2 años.                                                                                                         • Billes SK, Sinnayah P, Cowley MA. Naltrexone/bupropion for obesity: an investigational combination pharmacotherapy for weight loss.\n   B. La lorcaserina es un agonista selectivo de los receptores 5-HT2C que inhibe el apetito a                                              Pharmacol Res. 2014;84:1-11.\n       través de la vía melanocortinérgica (α-MSH-CART).\n   C.  La naltrexona estimula los receptores opioides de las neuronas productoras de β-endorfinas.\n   D.  El orlistat, sintetizado a partir de la lipostatina, inhibe la mayoría de las lipasas del tracto\n       gastrointestinal, bloqueando la digestión de los triglicéridos de la dieta.\n\n\n\n                                                                                                                                                                                                                                                                           429\n---\n                                                                                                                                                                                                              OBESIDAD,               LÍPIDOS                  8\n                                                                                                                                                                                  Y TRASTORNOS ELECTROLÍTICOS\n\n\n\n      9  En relación con la combinación bupropión-naltrexona, señale en qué situaciones                                                       se anastomosa al duodeno (rama alimentaria), cruzando a otra asa (biliopancreática) que\n         estaría contraindicada su administración:                                                                                            se anastomosa a 75-100 cm del íleon terminal (fig. 7).\n         A. En hipertensos.\n         B. En pacientes con antecedentes de crisis comiciales.\n         C. En pacientes con conductas alimentarias con atracones y picoteos.\n         D.  En pacientes con insuficiencia renal < 60 ml/min.\n\n\n\n         COMENTARIO\n         Las   contraindicaciones        formales según        ficha  técnica    de   la combinación       bupropión-nal-                              Gastrectomía vertical                                         Bypass gástrico\n         trexona quedan establecidas en: hipertensión descontrolada, crisis maniaca o trastorno\n         bipolar, glaucoma de ángulo estrecho, tratamiento con IMAO y antecedentes de crisis co-\n         miciales.\n         La toma de bupropión reduce el umbral convulsivo, especialmente si la medicación se\n         ingiere con comidas grasas (aumenta sus concentraciones), por lo que en pacientes con\n         epilepsia primaria o secundaria a un tumor o traumatismo del SNC estaría contraindi-\n         cada.\n         La combinación bupropión-naltrexona, por el contrario, está indicada particularmente en\n         pacientes con apetito, con especial predilección por el picoteo y/o los atracones, ya que                                                                        Mini-bypass gástrico                       Cruce duodenal\n         actúa en los núcleos de recompensa (accumbens o amígdala), disminuyendo la frecuencia\n         de estos episodios y contribuyendo a bajar de peso.                                                                                  Figura 7. Técnicas de cirugía bariátrica.\n         Referencias:\n         • Garvey WT, Mechanick JI, Brett EM, et al. Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. American Association     El bypass     gástrico estándar       y el  realizado    en   una anastomosis (o         mini-bypass  gástrico)\n           of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of\n           Patients with Obesity. Endocr Pract. 2016;22 Suppl 3:1-203.                                                                        pueden también modificarse para crear una mayor malabsorción, dejando el asa biliopan-\n                                                                                                                                              creática más larga (y excluida del paso del alimento). Son modificaciones técnicas que se\n                                                                                                                                              pueden emplear en sujetos superobesos con IMC > 45 kg/m2.\n     10  ¿Cuál de las siguientes técnicas de cirugía bariátrica tiene un mayor componente                                                     Referencias:\n         malabsortivo?                                                                                                                        • Rubio Herrera MA, et al. Manual de Obesidad mórbida. 2.ª ed. Madrid: Editorial Panamericana; 2015.\n         A. Bypass gástrico proximal en Y de Roux.\n         B. Cruce duodenal.\n         C. Bypass gástrico en una anastomosis (\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}